Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 5 | Brain shrinkage (cerebral atrophy), Absent speech, Inability to walk |
Muscles | 3 | Brain shrinkage (cerebral atrophy), Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia) |
Eyes | 2 | Nystagmus, Developmental cataract |
Ears | 1 | Hearing loss (hearing impairment) |
Heart and blood vessels | 1 | Widened subarachnoid space |
Age of onset: at birth.
Huppke-Brendel syndrome (HBS) is characterized by congenital cataracts, sensorineural hearing loss, and severe developmental delay in all reported children. One adult presented with less severe features. To date, 11 individuals (ten children and one adult) with HBS have been reported in the literature [, , , , , , ]. Ocular features. Bilateral congenital cataracts were reported in all affected individuals. Affected individuals presented with poor visual fixation and rotary nystagmus. Two individuals underwent cataract extraction in early infancy; there was improvement in visual fixation and nystagmus in one child and no improvement in vision in the other . Sensorineural hearing loss manifests during infancy. Brain stem auditory evoked potentials in two individuals showed absent waveforms.
Source: GeneReviews — "Huppke-Brendel Syndrome"
SLC33A1 function has not been fully characterized.
Huppke-Brendel syndrome is associated with mutations in the SLC33A1 gene on chromosome 3.
Formal diagnostic criteria for Huppke-Brendel syndrome (HBS) have not been established.
HBS should be suspected in individuals with the following clinical, radiographic, electrophysiologic, and laboratory findings.
Clinical findings
Bilateral congenital cataracts
Nystagmus
Sensorineural hearing loss
Severe developmental delay/ intellectual disability and regression of acquired milestones
Hypotonia
Seizures
Poor weight gain and growth deficiency
Radiographic findings (on brain MRI examination)
Cerebellar hypoplasia/ cerebellar atrophy
Cerebral atrophy
Hypomyelination/dysmyelination
White matter volume loss
Wide subarachnoid spaces
Posterior cranial fossa cyst
Electrophysiologic findings. Brain stem auditory evoked potentials show absent wave forms.
Laboratory findings
Source: GeneReviews — "Huppke-Brendel Syndrome"
Disorders with low copper and ceruloplasmin in the differential diagnosis of Huppke-Brendel Syndrome are listed in . Table 2. Differential Diagnosis of Huppke-Brendel Syndrome: Disorders of Copper Metabolism
Gene | Disorder | MOI | Features of Disorder |
|---|---|---|---|
AP1S1 | IDEDNIK syndrome (MEDNIK syndrome) | AR | serum ceruloplasmin total copper levels are common.; Hearing loss, DD/ID, cataracts (2 persons), sparse hair, hypotonia |
ATP7A | Menkes syndrome (See ATP7A-Related Copper Transport Disorders.) |
Genetic testing for SLC33A1 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for Huppke-Brendel syndrome. The disease remains an area of unmet medical need.
Gene therapy approaches for Huppke-Brendel syndrome have been reported in the published literature.
No clinical practice guidelines for Huppke-Brendel syndrome (HBS) have been published. In the absence of published guidelines, the following recommendations are based on the authors' personal experience managing individuals with this disorder.
To establish the extent of disease and needs in an individual diagnosed with HBS, the evaluations summarized (if not performed as part of the evaluation that led to the diagnosis) are recommended.
Table 3.
Huppke-Brendel Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment
Eyes | Ophthalmology eval | To assess for cataracts, reduced vision, abnormal ocular movement, best corrected visual acuity, refractive errors, strabismus
| Audiology eval | Incl brain stem auditory evoked response otoacoustic emissions testing
| • Complete neurologic assessment
EEG if seizures are suspected
|
Gastrointestinal/
| Gastroenterology/ nutrition/ feeding team eval | • To incl eval of aspiration risk nutritional status
Consider eval for gastrostomy tube placement in persons w/dysphagia /or aspiration risk.
| Developmental assessment | • To incl motor, adaptive, cognitive, speech-language eval
Eval for early intervention/ special education
| Orthopedics/ physical medicine rehab/ PT OT eval | To incl assessment of:
Source: GeneReviews — "Huppke-Brendel Syndrome"
View trials for Huppke-Brendel syndrome
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended.
Table 5.
Huppke-Brendel Syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency
| Ophthalmology eval | Per treating ophthalmologist(s)
| Audiology eval | Annually or per audiologist
| • Measure growth parameters.
Evaluate nutritional status safety of oral intake.
| At each visit
| Monitor developmental progress educational needs.
| Assess for new seizures/ monitor those w/seizures as clinically indicated.
| • Physical medicine, OT/PT assessment of mobility, self-help skills
Assess for scoliosis contractures.
| Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning).
OT = occupational therapy; PT = physical therapy
Source: GeneReviews — "Huppke-Brendel Syndrome"
Phenotype severity distribution: 11 always present features, 2 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Huppke-Brendel syndrome.
131 publications have been identified in PubMed for Huppke-Brendel syndrome. Kisho has analyzed 73 by research type. Research spans Basic Science / Preclinical (41%), Review / Meta-Analysis (33%), and Case Report / Case Series (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 30 | 41% |
Research summaries | 24 | 33% |
Patient case studies | 11 | 15% |
Disease patterns and progression | 5 | 7% |
New treatment approaches | 3 | 4% |
Jeysankar P (2026). [PMID: 42232190](https://pubmed.ncbi.nlm.nih.gov/42232190/). *J Cancer Immunol (Wilmington)*. [Basic Science / Preclinical]
Suzuki Y (2026). [PMID: 42208896](https://pubmed.ncbi.nlm.nih.gov/42208896/). *J Biol Chem*. [Basic Science / Preclinical]
Yang P (2026). [PMID: 41986354](https://pubmed.ncbi.nlm.nih.gov/41986354/). *Nat Commun*. [Basic Science / Preclinical]
George G (2026). [PMID: 41997865](https://pubmed.ncbi.nlm.nih.gov/41997865/). *Life Sci Alliance*. [Basic Science / Preclinical]
Albers M (2026). [PMID: 41917001](https://pubmed.ncbi.nlm.nih.gov/41917001/). *Nat Commun*. [Basic Science / Preclinical]
Kim CW (2026). [PMID: 42065238](https://pubmed.ncbi.nlm.nih.gov/42065238/). *J Clin Invest*. [Basic Science / Preclinical]
Antos A (2026). [PMID: 42122051](https://pubmed.ncbi.nlm.nih.gov/42122051/). *Diagnostics (Basel)*. [Review / Meta-Analysis]
Kwarteng EO (2026). [PMID: 41959348](https://pubmed.ncbi.nlm.nih.gov/41959348/). *bioRxiv : the preprint server for biology*. [Basic Science / Preclinical]
Ma M (2026). [PMID: 41915008](https://pubmed.ncbi.nlm.nih.gov/41915008/). *Journal of molecular cell biology*. [Basic Science / Preclinical]
Gupta SS (2025). [PMID: 40851064](https://pubmed.ncbi.nlm.nih.gov/40851064/). *Journal of neurodevelopmental disorders*. [Review / Meta-Analysis]
Data assembled from 7 of 12 sources · Last updated Sep 19, 2026, 5:38 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Huppke-Brendel syndrome
XL |
Low serum copper ceruloplasmin concentration; Hypotonia, sparse hypopigmented hair |
Wilson disease | AR | Low serum copper ceruloplasmin concentration; urinary copper excretion | Liver disease; Movement disorder; Kayser-Fleischer rings |
CCDC115 | Congenital disorder of glycosylation, type IIo (OMIM 616828) | AR | Low serum ceruloplasmin concentration; Hypotonia, DD |
Aceruloplasminemia | AR | Low serum copper ceruloplasmin concentration; Neurologic manifestations: ataxia, involuntary movements | Retinal degeneration; Diabetes mellitus |
SLC31A1 | Neurodegeneration seizures due to copper transport defect (OMIM 620306) | AR | Low serum ceruloplasmin concentration; Low serum copper concentration in persons w/severe phenotype |
Early-onset epileptic encephalopathy, severe neurodevelopmental delay, hypotonia VMA12 (TMEM199) | Congenital disorder of glycosylation, type IIp (OMIM 616829) | AR | Low serum ceruloplasmin concentration |
Source: GeneReviews — "Huppke-Brendel Syndrome"